Truist Cuts Price Target on Hims & Hers Health to $33 From $39, Keeps Hold Rating
Hims & Hers Health has an average rating of overweight and mean price target of $45.50, according to analysts…
29,490$
12,99%
Echtzeit-Aktienkurs Hims & Hers Health Inc.
Bid:
Ask:
Nachrichten zur Hims & Hers Health Inc. Aktie
Hims & Hers price target lowered to $33 from $39 at Truist
Truist analyst Jailendra Singh lowered the firm’s price target on Hims Hers to $33 from $39 and keeps a…
PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after markets rallied sharply on news that President Trump announced a…
Market Update: Trident Digital Tech Holdings, Tesla, Hims & Hers Health, and SoFi Technologies Experience Notable Market Activity
The stock market has recently witnessed significant movements among key players in the technology and healthcare sectors.…
Market Update: Trident Digital Tech Holdings, Tesla, Hims & Hers Health, And SoFi Technologies Experience Notable Market Activity
Winter Garden, Florida, 8th April 2025, FinanceWire…
Market Update: Trident Digital Tech Holdings, Tesla, Hims & Hers Health, and SoFi Technologies Experience Notable Market Activity
Winter Garden, Florida, 8th April 2025, FinanceWire…
Sei Investments Co. Reduces Stock Position in Hims & Hers Health, Inc. (NYSE:HIMS)
Sei Investments Co. reduced its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) by 1.0%…
Hims & Hers: CEO Dudum will in der Krise Marktanteile gewinnen
Trotz FDA-Rückschlag und Kursrutsch setzt Hims auf Expansion statt Rückzug – mit klarer Strategie über GLP-1 hinaus. Vom Nischenplayer…
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the…
Hims & Hers health PAO Becklund Irene sells shares worth $63,402 By Investing.com
Hims & Hers health PAO Becklund Irene sells shares worth $63,402…
Hims & Hers CFO Okupe Oluyemi sells $338,833 in stock By Investing.com
Hims & Hers CFO Okupe Oluyemi sells $338,833 in stock…
Hims & Hers health executive sells $63,402 in stock By Investing.com
Hims & Hers health executive sells $63,402 in stock…
Hims & Hers Health (NYSE:HIMS) Rises 5% Over Last Quarter Following Strong 2024 Earnings
Hims & Hers Health (NYSE:HIMS) recently experienced a 5% price increase over the past quarter, marked by significant corporate events.…
Hims & Hers Health (NYSE:HIMS) Rises 5% Over Last Quarter Following Strong 2024 Earnings
Hims & Hers Health (NYSE:HIMS) recently experienced a 5% price increase over the past quarter, marked by significant corporate events.…
Hims & Hers Acquires At-Home Lab Testing Facility
Hims & Hers recently introduced at-home lab testing through its platform. | The new capability will enable providers to help…
Hims & Hers : Telehealths billion-dollar surge
Hims & Hers is a telehealth platform specializing in sexual health, dermatology, mental health, and weight loss. Founded by Andrew…
Eli Lilly Vs. Hims & Hers In DTC Weight Loss Market? - There Is Only One Winner (NYSE:LLY)
Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges. Find out who is…
Eli Lilly Vs. Hims & Hers In DTC Weight Loss Market? - There Is Only One Winner
…
DTC obesity med market heats up: Eli Lilly taps knownwell, Hims & Hers adds new weight loss meds to platform
Hims & Hers is expanding access to Eli Lillys branded weight loss drug Zepbound and diabetes drug Mounjaro as well…
Analysts Stay Cautious on HIMS Stock amid Core Business Uncertainty
Hims & Hers Health Inc. (HIMS) is facing increased skepticism from investors and analysts over the sustainability concerns of its…
Zepbound Now Available Through Hims AND Hers
WEDNESDAY, April 2, 2025 (HealthDay News) -- The telehealth company Hims & Hers Health is expanding its weight-loss offerings by…
Why Hims & Hers Health Stock Couldnt Beat the Market Today
Hims & Hers Health (NYSE: HIMS) stock labored mightily on Wednesday, but in the end, it couldnt top the benchmark…
Hims & Hers Stock Rises 5% After Adding Zepbound And Mounjaro To Weight Loss Platform
Hims & Hers Health shares rose 5% Tuesday after announcing it will offer Eli Lilly’s Zepbound and Mounjaro through its…
Hims & Hers stock slipped as investors were left unimpressed with its new weight-loss drug options
The digital healthcare platform announced Tuesday that it has added Zepbound and generic liraglutide to its platform…
Hims & Hers stock slipped as investors were left unimpressed with its new weight-loss drug options
Hims & Hers (HIMS) stock slid Wednesday, a day after the company announced new weight-loss drug offerings — an update…
Zepbound now available through Hims & Hers
(HealthDay News) — The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to…
Analysts Stay Cautious on HIMS Stock amid Core Business Uncertainty
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…
Why Hims & Hers Health Stock Couldnt Beat the Market Today
Hims & Hers Health (NYSE: HIMS) stock labored mightily on Wednesday, but in the end, it couldnt top the benchmark…
Eli Lilly denies affiliation with Hims & Hers
Eli Lillys statement reflects the checkered past between the two companies.…